Biosenta Inc. Ceases Negotiations With Voran Group Ventures Ltd.
Biosenta Inc. Ceases Negotiations With Voran Group Ventures Ltd.
DisclaimerCALGARY, Alberta, May 31, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. ( "Biosenta") (CSE: ZRO) announces that, further to its news release dated October 12, 2022, it has ceased negotiations with Voran Group Ventures Ltd. in respect of the previously announced Memorandum of Understanding dated October 5, 2022, for the commercialization of Biosenta's Tri-Filler antimicrobial products in Canadian markets and worldwide.
阿尔伯塔省卡尔加里，2023年5月31日(环球通讯社)Biosenta Inc.(“Biosenta”)(CSE：ZRO)宣布，继于2022年10月12日发布新闻稿后，已停止与Voran Group Ventures Ltd.就先前于2022年10月5日宣布的谅解备忘录的谈判，该谅解备忘录是关于Biosenta的Tri-Filler抗菌产品在加拿大市场和全球市场的商业化。
About Biosenta Inc.
关于 Biosenta Inc.
Biosenta is a Canadian-based company that develops and manufactures a range of safe and environmentally sound chemical compounds for household and industrial applications.
Biosenta是一家总部位于加拿大的公司，开发和制造一系列用于家庭和工业应用的安全和环境无害的化合物。
Disclaimer
免责
The CSE has in no way passed upon the contents of this news release and further, has neither approved nor disapproved of the contents of this news release. Neither the CSE nor its Regulation Services Provider (as such term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
中证所对本新闻稿的内容绝不过问，对本新闻稿的内容既不批准也不反对。CSE及其监管服务提供商(该术语在CSE的政策中定义)均不对本新闻稿的充分性或准确性承担责任。
For Further Information please contact:
为 进一步 信息 请 联系方式：
Am Gill, President and CEO of Biosenta Inc. am@biosenta.com
我是吉尔，总裁，Biosenta Inc.首席执行官。邮箱：am@biosenta.com
